Related Experiment Videos
Aberrant HOXC expression accompanies the malignant phenotype in human prostate
Gary J Miller1, Heidi L Miller, Adrie van Bokhoven
1Department of Pathology, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA.
Cancer Research
|October 3, 2003
Summary
HOXC gene overexpression is linked to prostate cancer malignancy and metastasis. This suggests HOXC genes may drive prostate tumors toward androgen independence, impacting treatment strategies.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- HOX gene dysregulation is associated with various cancers.
- Specific HOX genes driving prostate malignancy remain unclear.
Purpose of the Study:
- Investigate the role of HOXC genes in prostate cancer progression.
- Determine if HOXC gene overexpression correlates with metastasis and androgen independence.
Main Methods:
- Degenerate reverse transcription-PCR to screen HOX gene clusters.
- Specific RT-PCR to quantify HOXC4, HOXC5, HOXC6, and HOXC8 expression.
- Laser capture microdissection of paired tumor and normal prostate cells.
Main Results:
- HOXC cluster genes were significantly upregulated in malignant prostate cell lines and lymph node metastases.
- Expression patterns of HOXC genes in lymph node metastases differed from benign cells and other tumor sites.
- HOXC gene overexpression was confirmed in primary tumor cells.
- HOXC8 overexpression suppressed androgen receptor transactivation in LNCaP cells.
Conclusions:
- HOXC gene overexpression is strongly associated with prostate cancer malignancy and metastasis.
- HOXC genes may contribute to the development of androgen independence in prostate cancer.
- Targeting HOXC genes could offer new therapeutic strategies for advanced prostate cancer.